{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T01:40:11Z","timestamp":1750902011272,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81241139","No. 81360511"],"award-info":[{"award-number":["No. 81241139","No. 81360511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00228-017-2346-8","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T04:34:00Z","timestamp":1507264440000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of breviscapine on CYP3A metabolic activity in healthy volunteers"],"prefix":"10.1007","volume":"74","author":[{"given":"Xuan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-zhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-4519","authenticated-orcid":false,"given":"Yong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"2346_CR1","doi-asserted-by":"publisher","unstructured":"Chu Q, Wu T, Fu L, Ye J (2005) Simultaneous determination of active ingredients in Erigeron breviscapus (Vant.) Hand-Mazz. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 37(3):535\u2013541. https:\/\/doi.org\/10.1016\/j.jpba.2004.11.018","DOI":"10.1016\/j.jpba.2004.11.018"},{"issue":"3","key":"2346_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","volume":"32","author":"FL Veerdonk van de","year":"2011","unstructured":"van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA (2011) Inflammasome activation and IL-1\u03b2 and IL-18 processing during infection. Trends Immunol 32(3):110\u2013116. https:\/\/doi.org\/10.1016\/j.it.2011.01.003","journal-title":"Trends Immunol"},{"issue":"3","key":"2346_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.phrs.2004.09.001","volume":"51","author":"H Liu","year":"2005","unstructured":"Liu H, Yang X, Tang R, Liu J, Xu H (2005) Effect of scutellarin on nitric oxide production in early stages of neuron damage induced by hydrogen peroxide. Pharmacol Res 51(3):205\u2013210. https:\/\/doi.org\/10.1016\/j.phrs.2004.09.001","journal-title":"Pharmacol Res"},{"issue":"9","key":"2346_CR4","doi-asserted-by":"publisher","first-page":"10667","DOI":"10.3390\/molecules170910667","volume":"17","author":"L Qian","year":"2012","unstructured":"Qian L, Shen M, Tang H, Tang Y, Zhang L, Fu Y, Shi Q, Li NG (2012) Synthesis and protective effect of scutellarein on focal cerebral ischemia\/reperfusion in rats. Molecules 17(9):10667\u201310674. https:\/\/doi.org\/10.3390\/molecules170910667","journal-title":"Molecules"},{"issue":"11","key":"2346_CR5","first-page":"36","volume":"33","author":"YX Ma","year":"2012","unstructured":"Ma YX, Ma T, Wang L, Song T (2012) Clinical efficacy of breviscapine plus metoprolol on ventricular arrhythmias in dilated cardiomyopathy patients. J Med Forum 33(11):36\u201337","journal-title":"J Med Forum"},{"issue":"7","key":"2346_CR6","first-page":"537","volume":"69","author":"Z Lin","year":"2014","unstructured":"Lin Z, Guo S, Yang C, Yu Y, Xu L, Liu G (2014) In vivo effects of scutellarin on the activities of CYP1A2, CYP2C11, CYP2D1, and CYP3A1\/2 by cocktail probe drugs in rats. Pharmazie 69(7):537\u2013541","journal-title":"Pharmazie"},{"issue":"9340","key":"2346_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","volume":"360","author":"DW Nebert","year":"2002","unstructured":"Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360(9340):1155\u20131162. https:\/\/doi.org\/10.1016\/S0140-6736(02)11203-7","journal-title":"Lancet"},{"issue":"16","key":"2346_CR8","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1016\/S0021-9258(18)99177-5","volume":"266","author":"FP Guengerich","year":"1991","unstructured":"Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266(16):10019\u201310022","journal-title":"J Biol Chem"},{"issue":"1","key":"2346_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.tpj.6500144","volume":"3","author":"DA Flockhart","year":"2003","unstructured":"Flockhart DA, Rae JM (2003) Cytochrome P450 3A pharmacogenetics: the road that needs traveled. Pharmacogenomics J 3(1):3\u20135","journal-title":"Pharmacogenomics J"},{"key":"2346_CR10","doi-asserted-by":"crossref","unstructured":"Gorski JC, Hall SD, Jones DR VandenBranden M, Wrighton SA (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem Pharmacol 47(9):1643\u20131653","DOI":"10.1016\/0006-2952(94)90543-6"},{"issue":"5439","key":"2346_CR11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","volume":"286","author":"WE Evans","year":"1999","unstructured":"Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286(5439):487\u2013491","journal-title":"Science"},{"issue":"2","key":"2346_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/17425255.2.2.171","volume":"2","author":"L Wojnowski","year":"2006","unstructured":"Wojnowski L, Kamdem LK (2006) Clinical implications of CYP3A polymorphisms. Expert Opin Drug Metab Toxicol 2(2):171\u2013182","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"2346_CR13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","volume":"54","author":"JK Lamba","year":"2002","unstructured":"Lamba JK, Lin YS, Schuetz EG, Thummel KE (2002) Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54(10):1271\u20131294","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2346_CR14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"348","author":"WE Evans","year":"2003","unstructured":"Evans WE, McLeod HL (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348(6):538\u2013549","journal-title":"N Engl J Med"},{"issue":"6","key":"2346_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra020021","volume":"348","author":"R Weinshilboum","year":"2003","unstructured":"Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348(6):529\u2013537","journal-title":"N Engl J Med"},{"issue":"4","key":"2346_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","volume":"27","author":"P Kueh","year":"2001","unstructured":"Kueh P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD et al (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27(4):383\u2013391","journal-title":"Nat Genet"},{"issue":"3","key":"2346_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","volume":"10","author":"DS Streetma","year":"2000","unstructured":"Streetma DS, Bertino JS Jr, Nafziger AN (2000) Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10(3):187\u2013216","journal-title":"Pharmacogenetics"},{"issue":"4","key":"2346_CR18","first-page":"231","volume":"60","author":"CB Eap","year":"2004","unstructured":"Eap CB, Buclin T, Hustert E, Bleiber G, Golay KP, Aubert AC, Baumann P, Telenti A, Kerb R (2004) Pharmacokinetics of midazolam in CYP3A4-and CYP3A5-genotyped subjects. Eur J Clin Pharmacol 60(4):231\u2013236","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2346_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-200404000-00005","volume":"14","author":"CB Eap","year":"2004","unstructured":"Eap CB, Fellay J, Buclin T, Bleiber E, Golay KP, Brocard M, Baumann P, Telenti A (2004) CYP3A activity measured by the midazolam test is not related to 3435 C > T polymorphism in the multiple drug resistance transporter gene. Pharmacogenetics 14(4):255\u2013260","journal-title":"Pharmacogenetics"},{"issue":"3","key":"2346_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007691-199806000-00013","volume":"20","author":"JA Carrillo","year":"1998","unstructured":"Carrillo JA, Ramos SI, Agundez JA, Martinez C, Benitez J (1998) Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A. Ther Drug Monit 20(3):319\u2013324","journal-title":"Ther Drug Monit"},{"issue":"7","key":"2346_CR21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","volume":"9","author":"H Wang","year":"2008","unstructured":"Wang H, Tompkins LM (2008) CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9(7):598\u2013610","journal-title":"Curr Drug Metab"},{"issue":"10","key":"2346_CR22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","volume":"28","author":"SR Faucette","year":"2000","unstructured":"Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM (2000) Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 28(10):1222\u20131230","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"2346_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1570-0232(02)00673-6","volume":"783","author":"MR Shiran","year":"2003","unstructured":"Shiran MR, Gregory A, Rostami-Hodjegan A, Tucke GT, Lennard MS (2003) Determination of midazolam and 1\u2032-hydroxymidazolam by liquid chromatography-mass spectrometry in plasma of patients undergoing methadone maintenance treatment. J Chromatogr B Analyt Technol Biomed Life Sci 783(1):303\u2013307. https:\/\/doi.org\/10.1016\/S1570-0232(02)00673-6","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"9","key":"2346_CR24","first-page":"2082","volume":"22","author":"J Liu","year":"2011","unstructured":"Liu J, Han XW, Li Q, Jiao JJ, Gao SN, Meng SR, Lou JS (2011) Effect of Breviscapinum on the Activity of CYP3A4 in Rats. Lishizhen Med Materia Medica Res 22(9):2082\u20132084","journal-title":"Lishizhen Med Materia Medica Res"},{"issue":"8","key":"2346_CR25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ptr.3723","volume":"26","author":"TY Jian","year":"2012","unstructured":"Jian TY, He JC, He GH, Feng EF, Li HL, Bai M, Xu GL (2012) Scutellarin inhibits cytochrome P450 isoenzyme 1A2 (CYP1A2) in rats. Phytother Res 26(8):1226\u20131230","journal-title":"Phytother Res"},{"issue":"5","key":"2346_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/jcph.446","volume":"55","author":"A Stockis","year":"2015","unstructured":"Stockis A, Watanabe S, Scheen AJ (2015) Effect of brivaracetam on CYP3A activity, measured by oral midazolam. J Clin Pharmacol 55(5):543\u2013548. https:\/\/doi.org\/10.1002\/jcph.446","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"2346_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2008.292","volume":"85","author":"DJ McConn","year":"2009","unstructured":"McConn DJ, Lin YS, Mathisen TL, Blough DK, Xu Y, Hashizume T, Taylor SL, Thummel KE, Shuhar MC (2009) Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis. Clin Pharmacol Ther 85(4):387\u2013393","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"2346_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00228-012-1437-9","volume":"69","author":"SC Mueller","year":"2013","unstructured":"Mueller SC, Drewelow B (2013) Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies. Eur J Clin Pharmacol 69(5):1127\u20131134. https:\/\/doi.org\/10.1007\/s00228-012-1437-9","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2346_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/tpj.2010.28","volume":"11","author":"D Wang","year":"2011","unstructured":"Wang D, Guo Y, Wrighton SA, Cooke GE, Sadee W (2011) Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J 11(4):274\u2013286. https:\/\/doi.org\/10.1038\/tpj.2010.28","journal-title":"Pharmacogenomics J"},{"key":"2346_CR30","doi-asserted-by":"publisher","unstructured":"Pallet N, Jannot AS, El Bahri M, Etienne I, Buchler M, de Ligny BH et al (2015) Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. Am J Transplant 15(3):800\u2013805. https:\/\/doi.org\/10.1111\/ajt.13059","DOI":"10.1111\/ajt.13059"},{"issue":"1","key":"2346_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/pgs","volume":"14","author":"M Hu","year":"2013","unstructured":"Hu M, Mak VWL, Xiao YJ, Tomlinson B (2013) Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia. Pharmacogenomics 14(1):25\u201334. https:\/\/doi.org\/10.2217\/pgs","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2346_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/187569209787582349","volume":"7","author":"M Hu","year":"2009","unstructured":"Hu M, Mak VWL, Chu TTY, Waye MMY, Tomlinson B (2009) Pharmacogenetics of HMG-CoA reductase inhibitors: optimizing the prevention of coronary heart disease. Curr Pharmacogenomics Person Med 7(1):1\u201326. https:\/\/doi.org\/10.2174\/187569209787582349","journal-title":"Curr Pharmacogenomics Person Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2346-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T01:03:52Z","timestamp":1750899832000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2346"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2346-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}